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Summary
In spite of being one of our most prominent bacterial
pathogens, the presence of small regulatory RNAs
(sRNAs) has not previously been investigated in
Mycobacterium tuberculosis. Post-transcriptional
regulation of gene expression by sRNA molecules
has been demonstrated in a wide range of pathogenic
bacteria and has been shown to play a signiﬁcant role
in the control of virulence. By screening cDNA librar-
ies prepared from low-molecular weight RNA from
M. tuberculosis we have identiﬁed nine putative sRNA
molecules, including cis-encoded antisense tran-
scripts from within open reading frames and trans-
encoded transcripts from intergenic regions. sRNAs
displayed differential expression between exponen-
tial and stationary phase, and during a variety of
stress conditions. Two of the cis-encoded sRNAs
were associated with genes encoding enzymes
involved in lipid metabolism, desA1 and pks12.
These sRNAs showed complementarity to multiple
M. tuberculosis genes, suggesting the potential to act
as both cis-encoded and trans-encoded sRNAs. Over-
expression of selected trans-encoded sRNAs had
profound impact on growth of M. tuberculosis and
M. smegmatis. This is the ﬁrst experimental evidence
of sRNAs in M. tuberculosis and it will be important to
consider the potential inﬂuence of sRNA regulation
when studying the transcriptome and the proteome of
M. tuberculosis during infection.
Introduction
Mycobacterium tuberculosis, the causative agent of tuber-
culosis, is one of the most successful human pathogens. It
is estimated that a third of the world’s population has
been infected, with new infections occurring at a rate of
approximately one per second. Less than 10% of infected
individuals go on to develop active disease, resulting in
around9millionnewcasesand1.6milliondeathsannually.
The remaining 90% will not develop any symptoms but the
bacteria may persist in the form of an asymptomatic latent
infection with the potential to reactivate at any time.
While the physiological state of M. tuberculosis during
active or latent infection remains poorly understood, con-
siderable efforts have been invested in exploring tran-
scriptional changes associated with bacterial adaptation
to changing environments in in vitro and cell culture
models. The genome of M. tuberculosis encodes 13
sigma factors, 11 two-component sensory transduction
systems, and over 100 annotated transcriptional regula-
tors (Cole et al., 1998); mutagenesis and transcriptional
proﬁling studies have implicated many of these in the
response to stress stimuli and during pathogenesis in
experimental models.
There is growing evidence in other bacteria that the
mechanisms for transcriptional control are complemented
by a post-transcriptional regulatory network dependent on
small regulatory RNA(sRNA) molecules, which can act by
base pairing or by interaction with proteins (Waters and
Storz, 2009). Most of the known base pairing sRNAs can
be divided into two categories: cis-encoded sRNAs that
are transcribed in the antisense orientation to their target
protein-encoding mRNA, and trans-encoded sRNAs that
are transcribed from intergenic regions, and which often
have multiple targets (Vogel and Wagner, 2007; Waters
and Storz, 2009). The latter category sometimes require
the help of the RNA chaperone Hfq depending on the
species (Bohn et al., 2007; Vogel and Wagner, 2007;
Vogel, 2009). sRNA binding can enhance or repress
translation of mRNA targets by base-pairing with the 5′
end of the mRNA at different locations relative to the
ribosome binding site and start codon, or can alter mRNA
stability by generating duplex molecules which act as
substrates for RNase III or RNase E (Gottesman, 2004;
2005; Vogel et al., 2004). Numerous sRNAs have been
described in Escherichia coli and it is estimated that the
genome may encode several hundred sRNAs (Vogel and
Sharma, 2005). Regulation by sRNAs has been impli-
cated in stress responses, in the bacterial cell cycle, and
also in the virulence of a range of enteric pathogens,
Listeria monocytogenes and Staphylococcus aureus
(Romby et al., 2006; Livny and Waldor, 2007; Padalon-
Brauch et al., 2008). The aim of the present study was to
investigate the occurrence of sRNAs in M. tuberculosis.
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sRNA molecules in bacteria (Vogel and Sharma, 2005).
The ﬁrst involves bioinformatic prediction by sequence
alignment of intergenic regions with known sRNAs,
together with identiﬁcation of appropriately positioned
signals for transcriptional initiation and termination (e.g.
(Argaman et al., 2001; Wassarman et al., 2001; Livny
et al., 2005; 2006). The relatively poor deﬁnition of tran-
scriptional signals in mycobacteria led us to take the alter-
native approach of direct analysis of low-molecular-weight
RNA molecules isolated from M. tuberculosis cultures
(RNomics, e.g. Vogel et al., 2003; Kawano et al., 2005).
We describe a set of nine putative sRNAs identiﬁed by this
approach and characterized by Northern blotting and tran-
script mapping by 5′ and 3′ RACE analysis.
Results
Cloning of small RNAs from M. tuberculosis
Previous reports have identiﬁed the two small structural
RNAs, tmRNA and RNaseP RNA from M. tuberculosis
(Svard et al., 1996; Mignard and Flandrois, 2007);
however, no regulatory RNAs have been identiﬁed to
date. Therefore our initial experiment was aimed at deter-
mining the actual presence and abundance of small tran-
scripts, regarded as putative sRNAs. Total RNA from
exponential and stationary growth phases was depleted
of rRNA, and labelled with 32P-pCp and RNA ligase. The
RNA was separated on a denaturing acrylamide gel and
visualized by phosphorimaging. Multiple abundant and
well-deﬁned small transcripts were observed, with a dif-
ference in the pattern of expression between the two
growth phases (Fig. S1). This prompted us to proceed
with further experiments.
As we had observed differential expression of
M. tuberculosis small transcripts, two independent cDNA
libraries were generated from exponential and stationary
phase cultures. Total RNAwas size fractionated, and tran-
scripts between 20 and 75 nucleotides were eluted from
the gel. The eluted RNA was tailed with CTP and an RNA
linker was attached to the 5′ end. The RNA was subse-
quently converted into cDNA, PCR ampliﬁed, cloned and
sequenced. A total of 192 clones were sequenced and
these fell into six categories according to the TubercuList
webserver (http://tuberculist.epﬂ.ch): 1: mRNA fragments
within open reading frames (ORFs) (11 clones); 2: rRNA
spacer fragments (5 clones); 3: tRNAfragments (1 clone);
4: unknown RNA encoded in intergenic regions (trans
candidates, 23 clones representing six unique regions
and 19 repeat clones, see below), named according to the
original library clones; 5: unknown RNA encoded anti-
sense to annotated ORFs (cis candidates, 4 clones),
named according to their antisense partner; 6: fragments
that could not be assigned to a single region due to small
size (< 17 base pairs) or chimeric sequence (149 clones).
The intergenic regions containing B11 and F6 were rep-
resented 16 and three times respectively, and in both
growth phases, indicating that transcripts from these
regions were relatively abundant.
The genomic positions and context of the unknown
RNAs were identiﬁed in order to determine the likelihood
of each to be a genuine sRNAor part of the adjacent gene
(Fig. 1). If an intergenic cDNA clone was encoded on the
opposite strand of an adjacent gene, or more than 100
base pairs from an adjacent gene on the same strand, it
was considered a valid sRNA candidate. Based on these
criteria most of the intergenic clones appeared to be inde-
pendent transcripts and not 5′ or 3′ UTRs. One clone was
located 5 base pairs upstream of Rv 2050 and therefore
considered to be the 5′ UTR of this gene and thus not
investigated further. The sizes and genome locations of
the remaining sRNA candidates are shown in Table 1.
Northern blots verify the presence of sRNAs in
M. tuberculosis
Our cDNA libraries identiﬁed nine sRNA candidates; ﬁve
trans-encoded (B11, B55, C8, F6 and G2) and four cis-
encoded [antisense (AS) to desA1, pks12, Rv 1726 and
Rv 1890c]. To further clarify if the identiﬁed candidates
were genuine sRNAs, we performed Northern blotting
with riboprobes complementary to the original cDNA
clones. Before hybridization the membranes were stained
with methylene blue to ensure uniform loading between
exponential and stationary phase RNA (not shown). The
results of the Northern blotting, shown in Fig. 2, demon-
strate signals corresponding to small transcripts from
each of the candidates. Judging from the signals on the
Northern blots the trans-encoded sRNAs were expressed
at signiﬁcantly higher levels than the cis-encoded ones.
All transcripts (except a faint ~70-nucleotide signal from
B11 exponential phase) were larger than the cloned frag-
ments, suggesting that the latter were probably degrada-
tion products. The majority of sRNAs were seen as more
than one transcript, and most of the transcripts appeared
to be differentially expressed and/or processed in the two
growth phases. The ASdes and ASpks blots showed a
signiﬁcant smear representing larger species (> 150
nucleotides), speciﬁcally in exponential growth, suggest-
ing the presence of larger transcripts/precursors in addi-
tion to the small transcripts. The C8 sRNA appeared as a
large smear with the majority of the signal between 110
and 140 nucleotides in exponential phase, less so in
stationary phase where a distinct band around 85 nucle-
otides was seen, suggesting extensive trimming of the
primary transcript to the 85-nucleotide RNA. In addition
there was a faint band around 55 nucleotides. A summary
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blotting is shown in Table 1.
Mapping of transcripts
sRNA transcripts were further characterized by RNA
ligase-mediated rapid ampliﬁcation of 5′ and 3′ comple-
mentary DNA ends (RLM-RACE). The 5′ ends were
mapped by comparing the RACE products obtained with
and without prior treatment with tobacco acid pyrophos-
phatase (TAP), which facilitates the differentiation of tran-
scription start sites from processed 5′ ends (Argaman
et al., 2001). By hydrolysing the terminal 5′-triphosphate
group found only in primary transcripts, TAP enables the
ligation of a 5′ linker to these transcripts thereby enhanc-
ing the signal from transcription start sites (see Experi-
mental procedures for details). The results, shown in
Fig. 3, suggest several putative transcription start sites,
indicated by arrows. Bands representing signiﬁcant 5′
ends were excised, cloned and sequenced. As the North-
ern blots in most cases indicated differential expression at
different stages of growth, we also performed 5′ RACE on
RNAfrom stationary phase (not shown).Asummary of the
identiﬁed 5′ ends is given in Table 1. Together the results
indicate that some of the RNAs contain a single distinct
and seemingly processed 5′ end (B11, B55, C8). F6 and
G2 as well as all the cis-encoded sRNAs appeared to
have several different 5′ ends, primary as well as pro-
cessed, of varying intensity. However, some of the larger
products from the F6 and G2 reactions turned out to be
concatemers of transcripts with the same 5′ end as the
library clones. As the concatemerization was TAP depen-
dent we consider these 5′ ends to be transcription start
sites. This means that G2 was the only trans-encoded
sRNA with more than one 5′ end, while all of the cis-
encoded RNAs had multiple 5′ ends.
In the case of B11 we identiﬁed a putative SigA pro-
moter immediately upstream of the 5′ end suggesting that
this may be a transcription start site (Fig. 4).
We also identiﬁed a putative SigF promoter upstream of
the F6 5′ end as well as slightly weaker similarities to the
SigB consensus, suggesting that this promoter could be
recognized by both sigma factors. In the case of G2 we
identiﬁed a possible SigC promoter upstream of one of the
Fig. 1. Genomic positions of sRNA
candidates. Schematic showing genome
locations of the four cis- and ﬁve
trans-encoded sRNA candidates as
determined by sequence analysis of the
cDNA library clones. sRNAs are shown as
black arrows with names of sRNA candidates.
The pks12 gene contains two identical copies
of the region encoding ASpks. Approximate
distances between cloned sequences and
ORF beginnings (cis candidates) or ﬂanking
ORFs (trans candidates) are indicated.
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shown consensus sequences strongly support the notion
of the identiﬁed 5′ ends being transcription start sites. Due
to the heterogeneity of M. tuberculosis promoters the
assignment of promoter sequences for the remaining
transcription start sites were somewhat more uncertain.
However, we did identify putative -10 boxes upstream of
C8 and B55, but no -35 boxes. The -10 region upstream
of the C8 5′ end was identical to the -10 box of the PCL1
promoter of the M. tuberculosis rrn operon, recognized by
SigA. The situation was similar for B55, which displayed
some homology to the -10 region of a SigA promoter but
no identiﬁable -35 region (Fig. 4).
As the RACE experiments did not indicate any tran-
scription start sites speciﬁc for stationary phase, we con-
clude that the observed differences in sizes between the
two growth phases were due to differential processing,
rather than different promoter usage.
We were able to identify likely terminators, consisting of
a stem-loop followed by a poly-U stretch, for B11, C8 and
F6. These were located 92, 127 and 101 nucleotides
downstream of their respective 5′ ends (including the ﬁrst
U of the poly U tail). In the case of B11 this would result in
a 93-nucleotide transcript in reasonably good agreement
with the Northern blot. The situation for C8 was not as
straightforward and hence we performed 3′ RACE to
verify the C8 3′ end (see below). In the case of F6, a
102-nucleotide transcript is in good accordance with the
faint signal of approximately 100 nucleotides seen on the
Northern blot. This transcript could then be processed to
the shorter and more abundant ~55-nucleotide transcript.
In order to map the remaining 3′ ends, we performed 3′
RACE. A poly-A tail was added to the RNA and 3′ RACE
was carried out as described in Experimental procedures.
In some cases an additional 3′ RACE was performed on
poly-C-tailed RNA for comparison. The 3′ ends thus iden-
Table 1. M. tuberculosis trans-encoded sRNAs.
sRNA
Clone(s)
(size)
Northern
(~size) 5′ end
a 3′ end
b
Transcript
(calculated size
c) Left gene Right gene
B11 69 (70), 85 4099478 4099386
U 93 Rv3660c; essential
Cons. hypothetical
Rv3661
Cons. hypothetical
B55 37 55 704187 704247 61 Rv0609A CT
d
Cons. hypothetical
Rv0610c hypothetical
C8 29 85–140 4168281 4168154
U
4168212
4168224
58, 70, 128 Rv3722c CT essential tRNA-Ser (serV)
F6 30 55, 100 293604 293641
293661
293705
U
38, 58, 102 Rv0243/fadA2 CT
Acetyl-CoA acyl transferase
Rv0244c/fadE5
Acyl-CoA dehydrogenase
G2 57 65 1915190
1915028
1914962
1914977
67, 214, 229 Rv1689/tyrS tyrosine tRNA
synthase; essential
Rv1690 /lprJ lipoprotein
sRNA
clone(s)
(size)
Northern
(~size) 5′ end
a 3′ end
b
Transcript
(calculated size
c) Complementary gene(s)
ASdes 30 75, 110 918264
918350
918365
918432
918412
918458
48, 63, 68, 83, 94,
109, 149, 169, 195
desA1/Rv0824c; essential fatty acid desaturase
(desA2/Rv1094; essential fatty acid desaturases)
e
ASpks 54 75, (200)
f 2299745
2299785
2299796
2299886
2299873
78, 89, 91, 102, 129,
142, 162
pks12/Rv2048c; polyketide synthase (PDIM synthesis)
(pks7, pks8, pks15; polyketide synthases)
e
AS1726 27 80 1952503
1952400
1952375
1952367
1952351
1952291 61, 77, 85, 110, 213 Rv1726; possible oxireductase
AS1890 36 110 2139419
2139466
2139548
2139594
2139656 63, 109, 191, 238 Rv1890c; unknown hypothetical
a. Listed are all 5′ ends determined by library clones and 5′ RACE; 5′ ends in bold indicate transcription start sites according to RACE.
b. 3′ ends are determined by RACE and/or by scrutiny in which case the position corresponds to the ﬁrst U in the terminator
U.
c. Transcript sizes show all the possible sizes from the 5′-and 3′ ends listed; ﬁgures shown in bold correspond to sizes seen on Northern blots.
d. CT indicates co-transcribed with sRNA. Genes listed as essential are according to predictions from transposon mutagenesis.
e. Additional genes that could in theory interact with sRNA.
f. Transcript only seen during certain stress conditions.
All co-ordinates shown are according to the TubercuList webserver; co-ordinates for ASpks are for one of two identical sRNA encoding regions.
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sizes on the Northern blots in order to identify accurate
transcript boundaries. Results of 3′ RACE analysis are
summarized in Table 1. In the case of C8 this approach
suggested two additional 3′ ends, which resulted in tran-
script sizes of 70 and 58 nucleotides respectively. One
scenario is that transcription of C8 ends at the suggested
terminator resulting in a 128-nucleotide transcript, with
progressive 3′ trimming generating the shorter transcripts.
However, the smear on the Northern blot suggests addi-
tional larger C8 species, indicating more distal promoters
and/or terminators. Some of the sRNAs contained start
codons (ATG and/or GTG) within the transcript bound-
aries, but most of the stop codons, for these reading
frames, were located downstream of the mapped 3′ ends.
However, the AS1726 transcript did contain a small ORF
of 99 nucleotides, and it is possible that this transcript
encodes a functional protein, although we could not iden-
tify a likely ribosome binding site.
Transcriptional coupling and sequence conservation
Apart from G2 all of the trans encoded sRNA candidates
were encoded on the same strand as one of the adjacent
protein-encoding genes (Fig. 1). This prompted us to test
by RT-PCR if these sRNAs were co-transcribed with the
particular upstream or downstream gene. Using primers
that spanned the sRNA and the adjacent gene, we found
that B55 was co-transcribed with the upstream Rv0609A
(Fig. S2). Together with the fact that the region between
Rv0609A and B55 is 100% conserved (in M. tuberculosis
complex only), this suggests the possibility that B55 is
part of the 3′ U T Ro ft h eRv0609A mRNA rather than
being an sRNA.Although we had identiﬁed two 3′ ends for
Fig. 2. Northern blots verify the presence of M. tuberculosis sRNAs. RNA from exponential (E) and stationary phase (S) cultures was
analysed by Northern blotting using riboprobes complementary to cDNA clones identiﬁed as sRNA candidates; A shows trans-encoded sRNAs;
B shows cis-encoded sRNAs. Transcript sizes are approximate and compared with Ambion’s Decade marker (M).
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and the downstream (essential) Rv3722c, we found that
C8 was co-transcribed with Rv3772c (Fig. S2). This would
explain the presence of the larger C8 species (seen as a
smear) on the Northern blot and furthermore suggests
that termination at the proposed terminator may not be
100% efficient. Sequence comparisons with other bacte-
rial genomes showed that the ﬁrst 90 nucleotides of C8
are highly conserved in mycobacteria as well as more
distantly related bacteria, i.e. Rhodococcus, Corynebac-
teria and Nocardia. Searching the Rfam database
(Griffiths-Jones et al., 2005; Gardner et al., 2009) with the
C8 sequence revealed that this RNA was in fact 4.5S
RNA, which is known to be trimmed extensively (Li et al.,
1998), but which has not previously been annotated in
M. tuberculosis. F6 was found to be co-transcribed with
the upstream fadA2. F6 itself was found to be highly
conserved in pathogenic mycobacteria, while the 3′ half
was less well-conserved in non-pathogenic mycobacteria
(Fig. S3). No RT-PCR product was obtained using primers
spanning B11 and Rv3660c, indicating that these two
genes are not co-transcribed and therefore B11 is a bona
ﬁde sRNA. The sequence of B11 was highly conserved in
a wide range of pathogenic mycobacteria as well as in the
non-pathogenic Mycobacterium smegmatis (Fig. S3).
Finally G2 was conserved only within the M. tuberculosis
complex.
We also tested if the genes for which we had identiﬁed
cis-encoded sRNAs, were co-transcribed with their down-
stream genes, because there was less than 100 base
pairs between these ORFs. The results indicate that all of
the presumed target genes were co-transcribed with a
Fig. 3. Mapping of 5′ ends with RACE. RLM-RACE analysis was used to map the 5′ ends of sRNA transcripts in TAP (+) and Mock (–)
treated samples. Transcription start sites (indicated by arrows) were identiﬁed on the basis of a stronger signal in TAP-treated samples.
Sequence analysis of TAP-dependent bands indicated by bracketed arrows in F6 and G2 identiﬁed them as concatamers with 5′ sequences
identical to original cDNA clones.
Fig. 4. Alignment of putative sRNA promoters with M. tuberculosis
promoter consensus sequences. Putative promoter motifs, found
immediately upstream of the identiﬁed 5′ ends of the trans-encoded
sRNAs, have been aligned to promoter motifs of the most likely
consensus sequence.
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cis-encoded sRNAs have the potential for post-
transcriptional modulation of the ratio between target
gene and its downstream partner (Fig. S2).
Prediction of secondary structure of sRNAs
Once we had identiﬁed the 5′ and 3′ termini of the tran-
scripts we assigned the most probable boundaries for the
transcripts seen on the Northern blots. Each of the result-
ing sequences was subsequently analysed using mfold
for prediction of secondary structures (Mathews et al.,
1999; Zuker, 2003). Strikingly all of the sequences, except
B55 and C8 (4.5S) had a C:G ratio > 1 (Fig. S4). In par-
ticular, the loops/single-stranded regions of the predicted
structures often contained unpaired, C-rich stretches
analogous to S. aureus RNAIII (Novick et al., 1993; Benito
et al., 2000). Of the trans-encoded sRNA candidates, B55
was the only predicted structure devoid of such a C-rich
loop. The sequences corresponding to M. smegmatis B11
and F6 was also subjected to this procedure, and
the resulting structures were almost identical to the
M. tuberculosis structures (not shown).
Expression of M. tuberculosis sRNAs during stress
Bacterial sRNAs are often stress induced. We wanted to
investigate how the expression of M. tuberculosis sRNAs
responded to stresses similar to those encountered
during infection. Therefore, we subjected cultures of
M. tuberculosis to oxidative stress (induced by H2O2),
DNA damage (induced by Mitomycin C) and acid stress.
Total RNAwas isolated and sRNAexpression detected by
Northern blotting and subsequently normalized to 5S RNA
levels to compensate for uneven loading. If an sRNA had
multiple bands, we quantiﬁed all the bands. Each signal
was compared with a control sample, i.e. unstressed,
exponential growth for oxidative stress and DNA damage,
and a pH control for the acid stress (see Experimental
procedures for details). A representative Northern blot for
each sRNAupon stress is shown in Fig. S5, and diagrams
showing each sRNA’s average response to stress are
shown in Fig. S6. From this experiment it was evident that
stress-induced expression varied signiﬁcantly between
sRNAs, with some remaining unchanged and others dis-
playing more than twofold increase upon stress. Oxidative
stress was the most potent inducer of differential expres-
sion with fold-induction ratios of 1.8, 2.4, 2.0 and 2.5 for
B11, B55, F6 and ASpks respectively (Table S2). The
increase in ASpks expression was associated with the
striking appearance of a novel ~200-nucleotide transcript
that we had not observed previously (Fig. 5). In addition,
F6 showed a twofold induction in response to acid stress.
Reproducible quantiﬁcation of C8 (i.e. 4.5S RNA) proved
difficult due to the transcript showing up as a smear rather
than distinct bands.
Overexpression of M. tuberculosis sRNAs
In order to gain some insight into the function of trans-
encoded sRNAs, B11, F6 and G2 were cloned in plasmid
vectors under the control of the strong rrnB promoter of
M. smegmatis (Arnvig et al., 2005) and transformed into
M. tuberculosis and M. smegmatis mc 2155. The con-
structs expressing B11 and G2 both proved lethal in
M. tuberculosis, while the expression of F6 resulted in
extremely slow growth with pin prick colonies visible after
3–4 weeks. Constructs with B11 and G2 driven by a
weaker promoters also led to cell death. The expression
of B11 in M. smegmatis had a pronounced phenotype with
very slow growth on plates and in liquid medium (Fig. 6A
and data not shown). Staining revealed that the cells were
elongated sometimes with lumps or protrusions (Fig. 6B),
suggesting that B11, which is highly conserved between
M. tuberculosis and M. smegmatis (Fig. S5), is involved in
some aspect of cell wall synthesis and/or cell division.
M. smegmatis expressing G2 also showed defective
growth, especially in liquid medium (not shown), in spite of
the absence of any obvious homologue of this sRNA in
the rapid-growing strain. The expression of F6 did not
result in any apparent growth defects in M. smegmatis,
Fig. 5. Northern blot of M. tuberculosis ASpks sRNA after stress.
The blot illustrates of the appearance of a novel ASpks transcript
upon induction with 10 mM H2O2. Lanes: exponential (–); 2: H2O2
treated; 3: Mitomycin C treated (MMC); 4: pH control; 5: acid stress
(pH 5.0).
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this sRNA is conserved (Fig. S3).
Discussion
We have shown here for the ﬁrst time experimental
evidence of sRNAs in M. tuberculosis. By screening
cDNA libraries prepared from low-molecular-weight
M. tuberculosis RNA, we cloned nine sRNAs which were
all readily visualized by Northern blotting and were further
characterized by mapping of 5′ and 3′ ends. All of the
cloned transcripts appeared to be degradation products of
the native sRNAs, judging from size differences detected
by Northern blot. All of the M. tuberculosis sRNAs display
stable predicted secondary structures and in most cases
a C:G ratio > 1. They include transcripts from intergenic
regions (trans-encoded sRNAs) as well as short anti-
sense transcripts encoded within ORFs (cis-encoded
sRNAs). One of the trans-encoded sRNAs was identiﬁed
as the M. tuberculosis homologue of the 4.5S RNA mol-
ecule that forms part of the signal recognition particle
involved in protein secretion (Driessen and Nouwen,
2008).
Although the percentage of putative sRNAs clones that
we obtained (13%) was high in comparison with that
reported using a similar approach with RNA from E. coli,
i.e. 3% (Kawano et al., 2005), we presume that we have
detected only a subset of the total repertoire of
M. tuberculosis sRNAs. Preliminary results of sequence-
based RNomic screens reveal multiple potential sRNA
signals for M. tuberculosis in addition to our initial set of
transcripts (K.B. Arnvig and N.R. Thomson, unpubl. obs.).
A recent bioinformatic screen in Streptomyces,a
related actinomycete, predicted 32 sRNAs, of which 20
were conﬁrmed experimentally (Panek et al., 2008), while
a similar screen using sRNAPredict2 predicted 56 sRNAs
in M. tuberculosis (Livny et al., 2006). None of our experi-
mentally isolated sRNAs were predicted by this method.
This could be due to the heterologous nature of the
M. tuberculosis promoters as well as the lack of canonical
terminator structure, which were part of the search param-
eters in their study. We do note, however, that Livny et al.
did not predict B11, which displays sequence homology to
SigA (i.e. sigma-70 like) promoters as well as having a
canonical terminator structure.
Neither Mycobacteria nor Streptomyces have identiﬁ-
able homologues of the Hfq RNA chaperone that has
been widely implicated in the mechanism of trans-
encoded sRNAs in Gram-negative bacteria (Sun et al.,
2002). Alternative pathways may be important for
sRNA regulation in GC-rich Gram-positive bacteria.
M. tuberculosis sRNAs contain C-rich stretches similar to
those found in Streptomyces (Panek et al., 2008). One
function of these regions could be initiating the interaction
A
B
Fig. 6. Overexpression of M. tuberculosis sRNAs in
M. smegmatis. A illustrates the growth on solid 7H11 of
M. smegmatis expressing B11, F6, G2 compared with empty vector.
B shows representative slides of stained M. smegmatis expressing
B11 compared with cells with empty vector. Cells were grown
overnight, resuspended in PBS + 5% Tween 80 and stained with
carbolfuchsin.
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S. aureus RNA III, which, incidentally, does not require
Hfq for function (Geisinger et al., 2006; Bohn et al., 2007).
Alternatively, it may be that C-rich stretches are recog-
nized by an alternative RNA chaperone that functions in
place of Hfq, analogous to the recognition of similar
sequences by eukaryotic RNA-binding proteins (Makeyev
and Liebhaber, 2002).
Northern blot analysis demonstrated variations in sRNA
expression between exponential and stationary growth
phases, and in response to environmental stress. Three of
the trans-encoded sRNAs were signiﬁcantly induced by
oxidative stress, for example, while the cis-encoded
ASpks was expressed at a higher level and in the form of
a longer transcript. These ﬁndings are consistent with
previous reports of a role for sRNAs in bacterial
responses to stress e.g. (Gottesman et al., 2006), and
suggest that sRNAs could be involved in adaptation of
M. tuberculosis to conditions encountered during infec-
tion, as it is the case for other pathogens (e.g. Romby
et al., 2006; Toledo-Arana et al., 2007).
While there has been a rapid increase in identiﬁcation
of bacterial sRNAs over the last few years, the identiﬁca-
tion of mRNA and protein targets has proceeded more
slowly (Vogel and Wagner, 2007). We can begin to specu-
late about the potential role of the cis-encoded sRNAs in
M. tuberculosis by examining the function of their anti-
sense partners. Interestingly, the two target ORFs with
known function – desA1 and pks12 – are both involved
in lipid metabolism. The fatty acid desaturase
DesA1 (Rv0824c) is an essential gene for growth of
M. tuberculosis (Sassetti et al., 2003) and is strongly
upregulated following uptake by macrophages and during
experimental infection in mice (Schnappinger et al.,
2003). ASdes shows signiﬁcant complementarity to a
second desaturase (desA2/Rv1094) (Fig. 7), and could
therefore regulate expression of both genes, acting as
both a cis-encoded and a trans-encoded sRNA. ASpks is
expressed as an antisense transcript within the pks12
gene, the largest ORF in M. tuberculosis. Polyketide syn-
thase (Pks) 12 is implicated in synthesis of mannosyl-b-
1-phosphomycoketide molecules, which are recognized
as antigens by CD1-restricted T cells (Matsunaga et al.,
2004). ASpks aligns with mRNA encoding duplicate iden-
tical ketosynthase domains between amino acid residues
404–458 and 2427-2481 (Gokhale et al., 2007). Similar
ketosynthase domains are present in of pks7, pks8 and
pks15, giving ASpks the potential to act as both cis-
encoded and trans-encoded sRNA depending on the
boundaries of the sRNA (Fig. 7).
It is more difficult to speculate on potential targets and
functions for the trans-encoded sRNAs, and the possibility
remains that some of these could be structural rather than
regulatory RNAs, as was the case of 4.5S RNA, meaning
they would not have mRNA targets as such. However,
genome and operon associations with genes of known
function may give a clue. Thus, F6 is located within a
region encoding enzymes involved in lipid metabolism as
well as co-transcribed with fadA2, for which the transcript
is downregulated in macrophages (Schnappinger et al.,
2003). Phenotypic changes resulting from experimental
manipulation of sRNA expression levels provide an alter-
native route to target identiﬁcation. Overexpression
of three trans-encoded sRNAs had profound effects
on mycobacterial growth. Strikingly, no colonies were
obtained for M. tuberculosis following transformation with
B11, while M. smegmatis transformants had major defects
affecting cell division and morphology. Overexpression of
G2 also prevented growth of M. tuberculosis and reduced
growth of M. smegmatis, while F6 reduced growth speciﬁ-
cally in M. tuberculosis. These experiments demonstrate
that sRNAs have a functional role in M. tuberculosis.W e
are currently following up on these observations using
regulated expression systems in combination with tran-
scriptome proﬁling to identify targets and mechanisms for
trans-encoded sRNA regulation.
In summary, our results provide the ﬁrst demonstration
that M. tuberculosis expresses sRNA molecules and that
Fig. 7. cis-encoded sRNA with trans-acting potential. Diagram illustrating the extent of complementarity between ASdes and ASpks and their
respective alternative targets, desA2 and pks7, 8 and 15.
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physiology. We anticipate that further functional studies in
combination with sequence-based RNomics will provide
novel insights into the fundamental biology of tuberculosis
with the potential to inform development of improved strat-
egies for disease control.
Experimental procedures
Strains and growth conditions
Escherichia coli DH5a was grown on Luria–Bertani agar with
50 mgm l
-1 kanamycin. M. tuberculosis laboratory strain
H37Rv was grown in Middlebrook 7H9 medium with 10%
ADC in roller bottle culture. Exponential phase cultures were
harvested at OD between 0.5 and 0.8; stationary phase cul-
tures were harvested 1 week after OD had reached 1.0.
M. smegmatis was grown in Middlebrook 7H9 with 10% ADC
and 20 mgm l
-1 kanamycin.
Stress stimuli
To induce oxidative stress, 30% H2O2 was added to an expo-
nentially growing culture (OD~0.6) to a ﬁnal concentration of
10 mM for 1 h. To induce DNA damage, Mitomycin C was
added to an exponentially growing culture (OD~0.3) at a ﬁnal
concentration of 0.02 mgm l
-1 for 24 h. Acid stress was
induced by spinning down an exponentially growing culture at
room temperature and resuspending in acidiﬁed medium
(pH 5.0) at 37°C to OD 0.3–0.4 and subsequently grown for
24 h. In order to take into account the hypoxia and cold shock
induced during centrifugation, a control culture was treated
identically but resuspended in standard 7H9 medium (pH 6.5)
and likewise grown for 24 h and used for normalizing the acid
stressed samples.
Plasmid construction
The overexpression vector was made by replacing the XbaI-
HindIII fragment containing the Hsp60 promoter in pMV261
(Stover et al., 1991) with the XbaI-HindIII fragment spanning
-200 to -8 of the rrnB promoter from M. smegmatis (Arnvig
et al., 2005). The vector was made such that the sRNA could
be inserted as a HindIII fragment downstream of the -10
region, and such that transcription would start at the mapped
+1 with none or one added nucleotide at the 5′ end. A syn-
thetic transcriptional terminator was made by annealing
oligos Term.F and Term.R (Table S1) and inserted at the
HindIII site downstream of the sRNA-3′ end in case the sRNA
terminator was not included or not sufficient. The sRNA
inserts were made by PCR (B11) or oligo annealing (F6 and
G2) using the oligos listed in Table S1. Plasmids were trans-
formed into mycobacteria by electroporation.
Oligonucleotides
The sequences of all RNAand DNAoligonucleotides used for
cDNA libraries, probe construction, RACE and RT-PCR are
listed in Table S1.
RNA isolation and handling
Cultures were cooled rapidly by the addition of ice directly to
the culture before centrifugation. RNAwas isolated by means
of the FastRNAPro blue kit from QBiogene/MP Bio according
to manufacturer’s instructions. Before
32P-pCp-labelling the
RNA was depleted of 16S and 23S rRNA by means of the
microbExpress kit from Ambion according to instructions.
Labelling of RNA
Depleted RNA was end-labelled with
32P-pCp (GE Health-
care) and RNA ligase (Ambion) according to instructions.
Riboprobes were made with Ambion’s mirVana miRNA Probe
construction kit using the cDNAcloned sequence as template
(Table S1) and
32P-UTP (800 mCi mmol
-1; GE Healthcare).
cDNA library construction
Total RNA from the two growth phases was separated and
poly-C-tailed using E. coli poly(A) polymerase (Ambion) and
CTP. The RNA was treated with TAP and a 5′ linker
(Table S1) was added according to instructions (Generacer
kit, Invitrogen). RNA was reverse transcribed with a mix of
oligo(dG) primers (GRdG3′, Table S1) and subsequently
PCR ampliﬁed with the same oligo(dG) primer mix and a
linker speciﬁc primer (GR5′, Table S1) using PuReTaq (GE
Healthcare). PCR products were cloned into pCRII-TOPO
(Invitrogen) and sequenced.
Northern blotting
Total RNA was separated on 8% or 10% denaturing acryla-
mide gels and electroblotted onto Ambion’s Brightstar
membranes. After UV cross-linking the membranes were
stained in 0.3 M sodium acetate containing 0.03% methylene
blue. The membranes were incubated overnight with ribo-
probes in UltrahybOligo and exposed to phosphorimaging
after washing. Stress-induced changes in RNA expression
were determined by densitometer-scanning of Northern blots.
Transcript sizes were compared with Ambion’s Decade
marker (10–150 nucleotides) and RNA marker low from
Abnova (20–500 nucleotides).
RACE
5′ RACE was carried out essentially as described by
Argaman et al. (2001), except the reverse transcription was
carried out using random primers and Superscript III
(Invitrogen). PCR ampliﬁcation of cDNA was performed with
PuReTaq using GR5′ (linker speciﬁc, Table S1) and genes-
speciﬁc reverse primers (Table S1). PCR reactions were
separated on 3.5% NuSieve agarose (Lonza) and bands of
interest were excised, cloned into pCR-II TOPO and
sequenced.
3′ RACE was performed by adding a poly(A) or poly(C) tail
to total RNA with E. coli poly-A-polymerase (Ambion),
reverse transcribing with Superscript III (Invitrogen) using the
GRdT oligo or GRdG oligo (Table S1) and ﬁnally PCR ampli-
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speciﬁc forward primers (Table S1).
RT-PCR
cDNA was made with random primers and Superscript II
(Invitrogen). A control reaction was carried out in parallel
without enzyme. A standard PCR reaction was subsequently
carried out with primers listed in Table S1.
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